FDA grants accelerated approval for Kebilidi (eladocagene exuparvovec-tneq) for the treatment of AADC deficiency – PTC Therapeutics
PTC Therapeutics, Inc. announced the FDA accelerated approval of its gene therapy for the treatment of AADC deficiency, the first-ever gene therapy approved in the United States that… read more.
